600 pregnant women will be included in the project and followed in a standardized manner during their pregnancy. On a regular basis blood- and urine samples will be taken throughout their pregnancy and until 1 month after delivery and analyzed for a large variety of coagulation factors in order to identify factors that might predict an increased risk of developing pre-eclampsia and/or cardiovascular events. In addition a DNA-sample is taken if consented in order to evaluate genetic factors.
Age
18–any
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Pregnant women attending the midwife at Hilleroed Hospital, Frederiksborg County, Denmark.
You may not be if
Mental disease.
Problems understanding or reading Danish.
Clareo Health | Prospective Study in Pregnant Women With Hypercoagulopathy
